Venous Stents Market to Reach US$ 2.4 Billion by 2034, Growing at a 7.2% CAGR | Transparency Market Research, Inc. [Yahoo! Finance]
Becton, Dickinson and Company (BDX)
Last becton, dickinson and company earnings: 2/6 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bd.com
Company Research
Source: Yahoo! Finance
As medical advancements continue, venous stents are playing an essential role in restoring physiological blood flow and improving patients' quality of life. Wilmington, Delaware, Transparency Market Research Inc. –, Dec. 09, 2024 (GLOBE NEWSWIRE) -- The global venous stents market (???????????), valued at approximately US$ 1.1 Billion in 2023, is projected to grow at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2034. By the end of the forecast period, the market is estimated to reach over US$ 2.4 Billion . This growth is driven by increasing incidences of venous disorders, advancements in stent technologies, and rising awareness of minimally invasive procedures. Venous stents are primarily used to treat conditions such as chronic deep vein thrombosis (DVT), post-thrombotic syndrome, May-Thurner syndrome, Nutcracker syndrome, and for patients receiving hemodialysis who face reduced blood flow due to grafts or fistulas. These stents play a critical role in restoring pro
Show less
Read more
Impact Snapshot
Event Time:
BDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BDX alerts
High impacting Becton, Dickinson and Company news events
Weekly update
A roundup of the hottest topics
BDX
News
- Global Live Cell Imaging Market: Advances and Growth Prospects [Yahoo! Finance]Yahoo! Finance
- Infusion Pump Market is expected to generate a revenue of USD 24.09 Billion by 2031, Globally, at 6% CAGR: Verified Market Research® [Yahoo! Finance]Yahoo! Finance
- Becton, Dickinson and Company (NYSE: BDX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- BDX Stock Down Despite New Expansion to Boost Fingertip Blood Testing [Yahoo! Finance]Yahoo! Finance
- Here's Why Becton Dickinson (BDX) is a Strong Value Stock [Yahoo! Finance]Yahoo! Finance
BDX
Earnings
- 11/7/24 - Beat
BDX
Sec Filings
- 12/20/24 - Form 4
- 12/19/24 - Form 144
- 12/19/24 - Form ARS
- BDX's page on the SEC website